Article Text

Download PDFPDF
Letter
Vedolizumab safety in pregnancy and newborn outcomes

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors DCB wrote the first draft. All authors edited and approved the final manuscript.

  • Competing interests MJ, JK and DCB have served as paid speakers on medical education events supported by and/or scientific advisors to Takeda, manufacturer of vedolizumab.

  • Patient consent Obtained.

  • Ethics approval Patients granted approval.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data sharing statement This data can be shared according to international guidelines.